Salvor Rafnsdottir

Salvor Rafnsdottir

Auto-generated profile, based on publicly available information

Salvor Rafnsdottir

Louma G. Laboratory of Epigenetic Research, Faculty of Medicine, University of Iceland, Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Cell Reports
Verified
Journal Article
Open access
SRSalvor Rafnsdottir
Salvor Rafnsdottir
KJKijin Jang
Kijin Jang
SHSara Tholl Halldorsdottir
Sara Tholl Halldorsdottir
MVMeghna Vinod
Meghna Vinod
ATArnhildur Tomasdottir
Arnhildur Tomasdottir
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
The mild hypothermia response (MHR) maintains organismal homeostasis during cold exposure and is thought to be critical for the neuroprotection documented with therapeutic hypothermia. To date, little is known about the transcriptional regulation of the MHR. We utilize a forward CRISPR-Cas9 mutagenesis screen to identify the histone lysine methyltransferase SMYD5 as a regulator of the MHR. SMYD5 represses the key MHR gene SP1 at euthermia. This repression correlates with temperature-dependent levels of histone H3 lysine 26 trimethylation (H3K36me3) at the SP1 locus and globally, indicating that the mammalian MHR is regulated at the level of histone modifications. We have identified 37 additional SMYD5-regulated temperature-dependent genes, suggesting a broader MHR-related role for SMYD5. Our study provides an example of how histone modifications integrate environmental cues into the genetic circuitry of mammalian cells and provides insights that may yield therapeutic avenues for neuroprotection after catastrophic events.

14 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSalvor Rafnsdottir
Salvor Rafnsdottir
KJKijin Jang
Kijin Jang
SHSara Tholl Halldorsdottir
Sara Tholl Halldorsdottir
MVMeghna Vinod
Meghna Vinod
ATArnhildur Tomasdottir
Arnhildur Tomasdottir
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
Organisms have homeostatic mechanisms to respond to cold to ensure survival including the activation of the neuroprotective mild hypothermia response (MHR) in mammals at 32°C. We show activation of the MHR by one FDA-approved medication, Entacapone, a proof-of-principle that the MHR can be medically manipulated. Utilizing a forward CRISPR-Cas9 mutagenesis screen, we identify the histone lysine methyltransferase SMYD5 as an epigenetic gatekeeper of the MHR. SMYD5 represses the key MHR gene SP1 at euthermia but not at 32°C. This repression is mirrored by temperature-dependent levels of H3K36me3 at the SP1-locus and globally indicating the mammalian MHR is regulated at the level of histone modifications. We identified 45 additional SMYD5-temperature dependent genes suggesting a broader MHR-related role for SMYD5. Our study provides an example of how the epigenetic machinery integrates environmental cues into the genetic circuitry of mammalian cells and suggests novel therapeutic avenues for neuroprotection after catastrophic events.